Advertisement

Index by author

November 01, 2004; Volume 32,Issue 11

  1. Wallace, Michael A.

    1. EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE
      Punam Sandhu, John S. Vogel, Mark J. Rose, Esther A. Ubick, Janice E. Brunner, Michael A. Wallace, Jennifer K. Adelsberger, Maribeth P. Baker, Paul T. Henderson, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition November 2004, 32 (11) 1254-1259; DOI: https://doi.org/10.1124/dmd.104.000422

  2. Wanders, Ronald J. A.

    1. VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA
      Margarida F. B. Silva, Lodewijk IJlst, Paul Allers, Cornelis Jakobs, Marinus Duran, Isabel Tavares de Almeida and Ronald J. A. Wanders
      Drug Metabolism and Disposition November 2004, 32 (11) 1304-1310; DOI: https://doi.org/10.1124/dmd.32.11.1304

  3. Wang, Bonnie

    1. THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
      Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182

  4. Wang, Regina W.

    1. CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216

  5. Weiss, H. Markus

    1. HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497

  6. Williams, J. Andrew

    1. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
Back to top

In this issue

Advertisement